The current list of studies for neurological conditions in Australia.
There are a vast number of clinical trials underway around the world focused on various neurological conditions ranging from epilepsy to Tourette’s syndrome and Alzheimer’s disease. Below you will find a current list of studies ongoing in Australia for patients with various neurological conditions.
More information can be found by clicking the “Study title” link or if the study is “Recruiting”, there is a link to the relevant study website/contact page to express your interest in participation.
|Trial status||Indication||Location||Age||Cannabinoid||Placebo arm||Study title||Study sponsor||More information|
|Recruiting||All indications||NSW, VIC, QLD, TAS, NT, ACT, SA, WA||18 – no limit||CACOS: CA Clinics Observational Study||Applied Cannabis Research||link|
|Recruiting||Epileptic encephalopathies||VIC||3-17||BELIEVE 1||Zynerba Pharmaceuticals||link|
|Recruiting||Fragile X syndrome||NSW, QLD, VIC||3-18||CONNECT-FX OLE||Zynerba Pharmaceuticals||link|
|Recruiting||Tourette’s syndrome||QLD||18-70||An RCT of Medicinal Cannabis in Adults with Tourette’s Syndrome||Wesley Medical Research Institute||link|
|Recruiting||Dementia||WA||65 – no limit||Medicinal cannabis use among dementia patients||University of Notre Dame Australia||link|
|Recruiting||All indications||NSW, VIC, QLD, TAS, NT, ACT, SA, WA||18 – no limit||BODOLOS||BOD Australia||link|
|Not yet recruiting||All indications||NSW, VIC, QLD, TAS, NT, ACT, SA, WA||No limit||Dosage patterns and efficacy of medicinal cannabis treatments in patients receiving medicinal cannabis for any condition||Cannvalate||Link|
Last updated 4 August 2020